SEC Form 4 · accession 0000884731-16-000081
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M Cole
Officer — SVP, Chief Business Officer
Period of report
Jun 27, 2016
Accepted (ET)
Jun 29, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 27, 2016 | M | 12,500 | $0.00 | A | 29,262 | D | |
| Common Stock | Jun 27, 2016 | M | 6,666 | $0.00 | A | 35,928 | D | |
| Common Stock | Jun 28, 2016 | S | 6,012 | $7.05 | D | 29,916 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3 | $0.00 | Jun 27, 2016 | M | 12,500 | D | — | — | Common Stock | 12,500 | 0 | D |
| Restricted Stock UnitsF4 | $0.00 | Jun 27, 2016 | M | 6,666 | D | — | — | Common Stock | 6,666 | 6,667 | D |
Explanation of responses
- F1Shares were acquired upon the vesting of an RSU granted June 25, 2014.
- F2Shares were sold to satisfy the Company's tax withholding obligations pursuant to an irrevocable election to sell to cover taxes previously authorized by the reporting person.
- F3Vests 50% per year on each of June 25, 2015 and 2016.
- F4Vests 33 1/3% per year on each of June 25, 2015, 2016 and 2017.